June 12, 2026 · Form 4 insider transaction
Agarwal Arjun bought 8,000 shares of Oruka Therapeutics, Inc. at $12.50 per share, a transaction worth $100.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Includes 888 shares acquired under the Oruka Therapeutics, Inc. stock purchase plan on June 8, 2026.